Skip to content
Search

Latest Stories

NHS to address workforce shortage by recruiting 2,000 doctors from India

NHS to address workforce shortage by recruiting 2,000 doctors from India
The shortage of doctors in the country is attributed to factors such as low wages, expensive training, and burnout due to heavy workload.

In a bid to address the ongoing deficit in staff in the UK’s healthcare system, the National Health Service (NHS) has entered into a new workforce agreement with India.

According to media reports, the healthcare service plans to hire 2,000 doctors from India on a fast-track basis to alleviate this pressing issue.


It is learned that the NHS has set up training centres across many Indian cities such as Mumbai, Bangalore, Nagpur, Delhi, Gurugram, Indore, Mysore, Chennai, and Calicut to provide postgraduate training for the first batch of doctors.

Post their training period (which ranges from six to 12 months), these doctors will be deployed at hospitals across Britain. They will also be exempted from the Professional and Linguistic Assessments Board (PLAB) examination that is otherwise mandatory for practising in the country.

According to a 2021 British Medical Association (BMA) report, the NHS was facing a shortfall of 49,000 full-time equivalent (FTE) doctors and medical staff. The health service has become extremely dependent on international recruitment due to chronic staff shortages. Currently, doctors trained overseas make up 25-30 per cent of the NHS' medical workforce.

The Welsh Health and Social Care Department has also announced a substantial investment of GBP 238 million in healthcare professional training, both domestically and internationally. As part of this initiative, 250 nurses and doctors from the Indian state of Kerala are slated to be recruited to work in NHS Wales.

Welsh Health Minister Eluned Morgan emphasised the significance of international recruitment in addressing workforce shortages, alongside sustained investments in domestic healthcare staff. Highlighting Kerala's track record in healthcare professional training and its positive impact on Welsh healthcare services, Morgan expressed optimism about the invaluable contribution of these future healthcare professionals to NHS Wales.

Morgan said: “Despite record number of nurses and other healthcare professionals in NHS Wales, the demand for health care workers globally has significantly increased. International recruitment, alongside our investment and commitment to home grown healthcare staff, is one of the ways we can fill the workforce gaps and rely less on agency staff.

“Kerala has a long history of training health care professionals and supporting them to come to Wales.”

The shortage of doctors in the country is attributed to factors such as low wages, expensive training, and burnout due to heavy workload, with Brexit exacerbating the issue.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less